These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2994613)

  • 1. Neutralization kinetic analysis of echovirus 30 and coxsackievirus B4 strains revealed little antigenic variation amongst the echovirus strains.
    Ash P; Leong WA; Kennett ML; Schnagl RD
    Aust J Exp Biol Med Sci; 1985 Apr; 63 ( Pt 2)():219-21. PubMed ID: 2994613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization kinetic analysis showed that strains of echovirus types 7, 11 and 17, unlike those of echovirus type 30, varied antigenically over time in Melbourne, Australia.
    Kirkwood CD; Kennett ML; Schnagl RD
    Acta Virol; 1988 May; 32(3):267-71. PubMed ID: 2902775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of conserved and nonconserved epitopes on Coxsackievirus B4: frequency of antigenic change.
    Prabhakar BS; Menegus MA; Notkins AL
    Virology; 1985 Oct; 146(2):302-6. PubMed ID: 2413617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact on routine diagnosis of echovirus infections of intratypic differentiation and antigenic variation in echovirus type 25 studied by using monoclonal antibodies.
    Peigue-Lafeuille H; Fuchs F; Gharabaghi F; Chambon M; Aymard M
    J Clin Microbiol; 1990 Oct; 28(10):2291-6. PubMed ID: 2229354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enterovirus strain isolated from diabetic child belongs to a genetic subcluster of echovirus 11, but is also neutralised with monotypic antisera to coxsackievirus A9.
    Al-Hello H; Paananen A; Eskelinen M; Ylipaasto P; Hovi T; Salmela K; Lukashev AN; Bobegamage S; Roivainen M
    J Gen Virol; 2008 Aug; 89(Pt 8):1949-1959. PubMed ID: 18632967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization epitope diversity of coxsackievirus B4 isolates detected by monoclonal antibodies.
    Webb SR; Kearse KP; Foulke CL; Hartig PC; Prabhakar BS
    J Med Virol; 1986 Sep; 20(1):9-15. PubMed ID: 2428930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology and dual serotype specificity detection of echovirus 11 strains in Finland.
    Savolainen-Kopra C; Al-Hello H; Paananen A; Blomqvist S; Klemola P; Sobotova Z; Roivainen M
    Virus Res; 2009 Jan; 139(1):32-8. PubMed ID: 19013201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of coxsackievirus group A. I. Serological variation of coxsackieviruses group A isolated in Gifu Prefecture].
    Miwa C
    Kansenshogaku Zasshi; 1998 Jan; 72(1):30-5. PubMed ID: 9503781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and phenotypic diversity of echovirus 30 strains and pathogenesis of type 1 diabetes.
    Paananen A; Savolainen-Kopra C; Kaijalainen S; Vaarala O; Hovi T; Roivainen M
    J Med Virol; 2007 Jul; 79(7):945-55. PubMed ID: 17516516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an echovirus type 30 variant isolated from patients with aseptic meningitis.
    Matsumoto K; Yokochi T; Matsuda S; Itoi Y; Kimura Y
    Microbiol Immunol; 1986; 30(4):333-42. PubMed ID: 2425228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies for study of antigenic variation in coxsackievirus type B4: association of antigenic determinants with myocarditic properties of the virus.
    Cao Y; Schnurr DP; Schmidt NJ
    J Gen Virol; 1984 May; 65 ( Pt 5)():925-32. PubMed ID: 6202831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A point mutation in VP1 of coxsackievirus B4 alters antigenicity.
    Halim S; Ramsingh AI
    Virology; 2000 Mar; 269(1):86-94. PubMed ID: 10725201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of capsid proteins of echovirus type 25 wild-type strain and prototype strain, studied by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting.
    Peigue-Lafeuille H; Bailly JL; Fuchs F; Chambon M; Aymard M
    J Clin Microbiol; 1991 Sep; 29(9):1780-4. PubMed ID: 1774296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and antigenic analyses of newly isolated strains of Echovirus type 7.
    Oishi I; Otsu K; Kunita N
    Biken J; 1971 Jun; 14(2):141-8. PubMed ID: 5001134
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.
    Morgan-Capner P; McSorley C
    J Hyg (Lond); 1983 Jun; 90(3):333-49. PubMed ID: 6306097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxsackievirus B4 heterogeneity: effect of passage on neutralization and mortality.
    Hartig PC; Webb SR
    Acta Virol; 1986 Nov; 30(6):475-86. PubMed ID: 2881467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of non-neutralizing monoclonal antibodies in an ELISA for intratypic differentiation of 28 echovirus type 25 clinical isolates.
    Peigue-Lafeuille H; Bailly JL; Aymard M; Fuchs F
    J Virol Methods; 1992 Jan; 36(1):91-9. PubMed ID: 1372613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cuban epidemic neuropathy. II. The antigenic characteristics of the viral isolates].
    Más Lago P; Guzmán MG; Muné M; Resik S; Alvarez M
    Rev Cubana Med Trop; 1995; 47(1):16-20. PubMed ID: 9805061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of echovirus type 17: comparison of the two lines of the prototype strain.
    Hara M; Tagaya I
    Intervirology; 1973; 1(3):185-92. PubMed ID: 4204550
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of the N-terminal part of the neutralizing antigenic site I of coxsackievirus B4 by mutation analysis of antigen chimeras.
    McPhee F; Zell R; Reimann BY; Hofschneider PH; Kandolf R
    Virus Res; 1994 Nov; 34(2):139-51. PubMed ID: 7531922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.